Proteomics uncovers molecular features for relapse risk stratification in patients with diffuse large B-cell lymphoma

• Maja Ludvigsen,
• Amanda Jessica Campbell,
• Marie Beck Enemark,
• Trine Engelbrecht Hybel,
• Marja-Liisa Karjalainen-Lindsberg,
• Klaus Beiske,
• Mette Bjerre,
• Lars Møller Pedersen,
• Harald Holte,
• Sirpa Leppä,
• Judit Meszaros Jørgensen,
• Bent Honoré

Affiliations

Maja Ludvigsen

Department of Hematology, Aarhus University Hospital

Amanda Jessica Campbell

Department of Clinical Medicine, Aarhus University

Marie Beck Enemark

Department of Hematology, Aarhus University Hospital

Trine Engelbrecht Hybel

Department of Hematology, Aarhus University Hospital

Marja-Liisa Karjalainen-Lindsberg

Department of Pathology, Helsinki University Hospital

Klaus Beiske

Department of Pathology, Division of Cancer Medicine, Oslo University Hospital

Mette Bjerre

Medical/Steno Aarhus Research Laboratory, Department of Clinical Medicine, Aarhus University

Lars Møller Pedersen

Zealand University Hospital

Harald Holte

Department of Oncology, Oslo University Hospital

Sirpa Leppä

Research Program Unit, Applied Tumor Genomics, Faculty of Medicine, University of Helsinki

Judit Meszaros Jørgensen

Department of Hematology, Aarhus University Hospital

Bent Honoré

Department of Biomedicine, Aarhus University